Concepedia

Kyle Glover

KG

Statistics

Publications

17

Citations

2.7K

H-Index

15

Active since

2009

Affiliations

DuPont (United States)(Current)

U.S. Army Combat Capabilities Development Command Chemical Biological Center

United States Army Medical Research and Development Command

Defense Threat Reduction Agency

Telemedicine & Advanced Technology Research Center

Kyle Glover is an author at DuPont (United States) specializing in pharmacy, toxicology, and pharmacotherapy.

Publications per year

2009–2023

17

Publications

17

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

In silico toxicology protocols

Glenn J. Myatt, Ernst Ahlberg, Yumi Akahori et al. · Regulatory Toxicology and Pharmacology · 2018 · 241 citations · Full text

Pharmacy, Toxicology, Developmental Toxicology +11

1–5 of 17